For release: 17 November 2017
2017 Annual Report and AGM Notice
genedrive plc (LSE: GDR), the near patient molecular diagnostics company, gives notice that copies of its 2017 Annual Report and Notice of the 2017 Annual General Meeting have been posted to shareholders. The AGM will be held at 12:00 on 29 November 2017 at the Company's premises at The Innovation Centre, 48 Grafton Street, Manchester M13 9XX.
Copies of these documents may be found on the Company's website (www.genedriveplc.com)
- Ends -
For further details please contact:
genedrive plc |
+44 (0)161 989 0245 |
David Budd: CEO |
|
Matthew Fowler: CFO |
|
|
|
Peel Hunt LLP |
|
James Steel |
+44 (0)207 418 8900 |
Oliver Jackson |
|
|
|
Consilium Strategic Communications |
+44 (0)203 709 5700 |
Chris Gardner |
|
Matthew Neal |
|
Laura Thornton |
|
[email protected] |
|
Notes to Editors
About genedrive plc
genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® platform and MTB/RIF test have been launched in India and a Genedrive® HCV test has received CE-IVD Certification.
Further details can be found at: www.genedriveplc.com and www.genedrive.com
